The MRPL3 gene helps mitochondria, the parts of cells that make energy, build the proteins they need to keep the body running. This gene plays an important role in tissues with high energy needs, such as the brain, muscles, and heart. If the gene does not work properly, cells may not make enough energy. More disruptive variants in both copies of the MRPL3 gene can cause a rare mitochondrial condition that may lead to developmental delay, low muscle tone, seizures, or heart problems.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or manage processes throughout the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others are used mainly to regulate when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, and medicines. For a deeper look at this subject, more information is available in the LearnHub.
Overview
MRPL3Gene function
What if the gene works
The MRPL3 gene helps make a protein in mitochondria, the parts of cells that produce energy. This protein helps mitochondria build other proteins needed for normal energy production.
Risk
What if the gene does not work
More disruptive variants in the MRPL3 gene can cause a mitochondrial condition that often begins in infancy, with low muscle tone, developmental delay, lactic acid buildup, and heart involvement. Milder variants may lead to later onset or less severe features.
Treatment
What does that mean for your treatment
No MRPL3-specific treatment or drug selection approach is currently established for pathogenic variants in the MRPL3 gene. Care is supportive and based on the person’s symptoms and organ involvement rather than the variant itself.
Conditions associated with MRPL3
Gene function
What if the gene works
Your cells use the MRPL3 gene to keep mitochondria making key proteins. Understanding MRPL3 gene function helps explain how these structures turn food and oxygen into usable energy. This job matters throughout the body and is especially important in organs that need a constant energy supply.
The MRPL3 gene helps mitochondria build a small set of proteins from mitochondrial DNA. These proteins become core parts of the system that makes cellular energy.
MRPL3 forms part of the large section of the mitochondrial ribosome, the protein making machine inside mitochondria. It helps this machinery stay organized while new proteins are assembled.
By supporting protein production in mitochondria, the MRPL3 gene helps cells make ATP, the main form of usable energy. This steady energy supply supports everyday work in tissues such as muscle, heart, and brain.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MRPL3 gene can weaken the mitochondrial ribosome, the cell’s protein making machinery inside mitochondria, so fewer energy related proteins are made. This is how MRPL3 gene variants affect mitochondrial protein making and lower mitochondrial energy output. Some changes leave the protein partly active, while more disruptive variants can make it unstable or prevent it from joining the ribosome at all. In people with two severe variants, symptoms often begin earlier and tend to be more pronounced.
How variants are linked to conditions
Pathogenic variants in the MRPL3 gene, usually affecting both copies, cause a rare mitochondrial condition called combined oxidative phosphorylation deficiency. In reports on MRPL3 gene variants linked to mitochondrial disease, children with this condition have had developmental delay, low muscle tone, growth problems, hearing loss, and sometimes heart or brain involvement. This is a confirmed genetic diagnosis rather than a general risk signal.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are found throughout the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link, not a certain diagnosis, particularly when several genes and environmental influences also play a role. There are cases, though, where one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the MRPL3 gene. For many living with an MRPL3 change, risk depends mainly on the exact genetic change and family pattern rather than lifestyle. Anyone with concerns about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of MRPL3 variants
MRPL3-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one altered copy of the MRPL3 gene from each parent, and the parents are often healthy carriers. When both parents carry an MRPL3 variant, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither altered copy. In practical terms, how MRPL3 gene variants are inherited usually follows this two-carrier pattern within a family.
What does my MRPL3 result mean for my family?
MRPL3-related illness is passed down in a recessive way, so family members usually matter most as possible carriers. Brothers and sisters of an affected child may also be affected or may be carriers, while parents are typically healthy carriers. Other close relatives, such as aunts, uncles, and cousins on both sides of the family, may also carry the same gene change.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the MRPL3 gene, doctors use genetic testing on a blood sample or saliva sample. MRPL3 genetic testing usually reads the gene as part of a multigene panel, exome sequencing, or genome sequencing and checks for variants that may help explain a person’s symptoms or family history.
When should I consider getting a genetic test?
Consider genetic testing that includes the MRPL3 gene if a child has signs of a rare inherited condition that affects how cells make energy, such as major developmental delay, low muscle tone, seizures, or unexplained heart problems. Testing can also make sense when these problems run in the family or when earlier genetic results point toward MRPL3.
A genetic result is only one part of your health story
Genetic test results can be informative, but how much they explain varies by the condition and the specific type of variant. Over time, the way the body functions is also shaped by factors such as lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, these results can also help place a person’s experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or reacts to it at its target. This is one reason the same medication may help one person a lot, help another only a little, or cause more side effects in someone else. These differences are common and are one part of why treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medicines. It looks at gene and drug patterns to help explain why the same treatment may work differently in different people. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the MRPL3 gene
When should I seek medical advice?
There is not a broadly confirmed role for this gene in predicting how medicines will work or which side effects may happen. For questions about symptoms, a new diagnosis, or concerns about any medicine you take, it is best to speak with your doctor or pharmacist.